New Lymphona Treatment Shows Promise

(NBC News) - A new approach to treating an incurable form of non-Hodgkin's lymphoma is showing promise. Researchers say a one-week course of a drug led to tumor shrinkage in 95 percent of lymphoma patients who hadn't undergone chemo. Seventy-five percent had their tumors completely eliminated. The drug, called Bexxar, works by targeting and delivering radiation to cancer cells. Patients with foliicular lymphoma typically receive months of chemotherapy as their first line treatment and the cancer typically relapses. Researchers say more study is needed to determine the ideal sequence of drugs for these patients. Research was conducted by the University of Michigan. It is published in the New England Journal of Medicine. The Bexxar drug regimen is administered twice in a one week period. The drug is marketed by Glaxosmithkline

No comments:

Blog Archive